72
Views
215
CrossRef citations to date
0
Altmetric
Original Article

Primary Sclerosing Cholangitis: A Long-Term Follow-up Study

, , , , , & show all
Pages 655-664 | Received 10 Feb 1987, Accepted 03 Mar 1987, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (19)

Erik Schrumpf, Kirsten Muri Boberg & Tom H. Karlsen. (2015) Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 50:6, pages 781-796.
Read now
Lars Aabakken. (2015) Scandinavian journal of gastroenterology – the editors-in-chief. Scandinavian Journal of Gastroenterology 50:6, pages 630-635.
Read now
Rune Isene, Tomm Bernklev, Ole Høie, Pia Munkholm, Epameonondas Tsianos, Reinhold Stockbrügger, Selwyn Odes, Øyvind Palm, Milada Småstuen & Bjørn Moum. (2015) Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scandinavian Journal of Gastroenterology 50:3, pages 300-305.
Read now
Vicente Valero$suffix/text()$suffix/text(), David Cosgrove, Joseph M Herman & Timothy M Pawlik. (2012) Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Review of Gastroenterology & Hepatology 6:4, pages 481-495.
Read now
Emmanouil Sinakos & Keith Lindor. (2010) Treatment options for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 4:4, pages 473-488.
Read now
Gabriele I. Kirchner, Gabriele I. Kirchner, Jens J. W. Tischendorf, Jörg Bleck, Siegfried Wagner, Martin Caselitz, Juergen Klempnauer, Michael P. Manns & Michael Gebel. (2008) Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma. Scandinavian Journal of Gastroenterology 43:11, pages 1366-1370.
Read now
B. Brandsæter, S. Friman, U. Broomé, H. Isoniemi, M. Olausson, L. Bäckman, B. Hansen, E. Schrumpf, A. Oksanen, B.‐G. Ericzon, K. Höckerstedt, H. Mäkisalo, P. Kirkegaard & K. Bjøro. (2003) Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scandinavian Journal of Gastroenterology 38:11, pages 1176-1183.
Read now
P. AITOLA, J. MATTILA, M. MATIKAINEN. (1998) Hepatobiliary Changes in Patients with Ulcerative Colitis, with Special Reference to the Effect of Proctocolectomy. Scandinavian Journal of Gastroenterology 33:2, pages 113-117.
Read now
H. H. Rasmussen, J. F. Fallingborg, P. B. Mortensen, M. Vyberg, U. Tage-Jensen & S. N. Rasmussen. (1997) Hepatobiliary Dysfunction and Primary Sclerosing Cholangitis in Patients with Crohn's Disease. Scandinavian Journal of Gastroenterology 32:6, pages 604-610.
Read now
D. Kornfeld, A. Ekbom & T. Ihre. (1997) Survival and Risk of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: A Population-Based Study. Scandinavian Journal of Gastroenterology 32:10, pages 1042-1045.
Read now
B. Heikius, S. Niemelä, J. Lehtola, T. Karttunen & S. Lähde. (1997) Hepatobiliary and Coexisting Pancreatic Duct Abnormalities in Patients with Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 32:2, pages 153-161.
Read now
M. H. K. Leidenius, M. A. Färkkila, P. Kärkkäinen, E. I. Taskinen, I. H. Kellokumpu & K. A. V. Höckerstedt. (1997) Colorectal Dysplasia and Carcinoma in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 32:7, pages 706-711.
Read now
I. J. Klompmaker, E. B. Haagsma, R. Verwer, P. L. M. Jansen & M. J. H. Slooff. (1996) Primary Sclerosing Cholangitis and Liver Transplantation. Scandinavian Journal of Gastroenterology 31:sup218, pages 98-102.
Read now
K. M. Boberg, K. E. A. Lundin & E. Schrumpf. (1994) Etiology and Pathogenesis in Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 29:sup204, pages 47-58.
Read now
K. M. Boberg, E. Schrumpf, O. Fausa, K. Elgjo, F. Kolmannskog, T. Haaland & E. Holter. (1994) Hepatobiliary Disease in Ulcerative Colitis: An Analysis of 18 Patients with Hepatobiliary Lesions Classified as Small-Duct Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 29:8, pages 744-752.
Read now
P. C. Van De Meeberg & K. J. Van Erpecum. (1993) Therapy with Ursodeoxycholic Acid in Cholestatic Liver Disease. Scandinavian Journal of Gastroenterology 28:sup200, pages 15-20.
Read now
H. H. Rasmussen, J. Fallingborg, P. B. Mortensen, L. Freund, U. Tage-jensenv. Kruse & S. N. Rasmussen. (1992) Primary Sclerosing Cholangitis in Patients with Ulcerative Colitis. Scandinavian Journal of Gastroenterology 27:9, pages 732-736.
Read now
V. Wewer, C. Gluud, P. Schlichting, F. Burcharth & V. Binder. (1991) Prevalence of Hepatobiliary Dysfunction in a Regional Group of Patients with Chronic Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 26:1, pages 97-102.
Read now
Erik Schrumpf, Olav Fausa & Erling Aadland. (1987) Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 22:6, pages 641-643.
Read now

Articles from other publishers (196)

Debashree Debasish Das, Nikita Sharma & Pooja A Chawla. (2022) Current trends and future perspectives in the treatment of PBC and PSC: A review. Health Sciences Review 5, pages 100065.
Crossref
Tom K. Lin, Maisam Abu-El-Haija, Juan P. Gurria, Michelle Saad & David S. Vitale. (2022) Interventional endoscopy for abdominal transplant patients. Seminars in Pediatric Surgery 31:3, pages 151190.
Crossref
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago & Roberto Grassia. (2021) Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 13:12, pages 1828-1849.
Crossref
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford & Edoardo V. Savarino. (2021) Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 161:6, pages 1865-1877.
Crossref
Guri Fossdal, Anders B. Mjelle, Kristine Wiencke, Ida Bjørk, Odd Helge Gilja, Trine Folseraas, Tom Hemming Karlsen, William Rosenberg, Lasse M. Giil & Mette Vesterhus. (2021) Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF. JHEP Reports 3:5, pages 100328.
Crossref
Marco Folci, Giacomo Ramponi, Virginia Solitano & Enrico Brunetta. (2021) Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis. Clinical Reviews in Allergy & Immunology 63:2, pages 107-123.
Crossref
William Balistreri & Simon Lam. 2021. Liver Disease in Children. Liver Disease in Children 333 347 .
Jay H. Lefkowitch. 2021. Scheuer's Liver Biopsy Interpretation. Scheuer's Liver Biopsy Interpretation 58 88 .
Kourosh M. Shirazi, Yasaman Hosseinzadeh, Zahra Nourpanah, Arman M. Shirazinezhad & Zeinab Nikniaz. (2019) The value of serum CA19‐9 in predicting primary sclerosing cholangitis in patients with ulcerative colitis. Advances in Digestive Medicine 7:3, pages 147-151.
Crossref
Melissa Palmer, Arie Regev, Keith Lindor, Mark I. Avigan, Lara Dimick‐Santos, William Treem, John F. Marcinak, James H. Lewis, Frank A. Anania, Daniel Seekins, Benjamin L. Shneider & Naga Chalasani. (2019) Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics 51:1, pages 90-109.
Crossref
Andreas L. Koutsoumpas, George Efthymiou, Maria G. Mytilinaiou & Dimitrios P. Bogdanos. 2020. Liver Diseases. Liver Diseases 153 159 .
Sanjay K. Murthy & Geoffrey C. Nguyen. 2019. Cancer Screening in Inflammatory Bowel Disease. Cancer Screening in Inflammatory Bowel Disease 1 15 .
Moira B. Hilscher, James H. Tabibian, Elizabeth J. Carey, Christopher J. Gostout & Keith D. Lindor. (2018) Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices. Hepatology Communications 2:7, pages 836-844.
Crossref
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn & Mette Vesterhus. (2017) Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 67:6, pages 1298-1323.
Crossref
Will R. Takakura, James H. Tabibian & Christopher L. Bowlus. (2017) The evolution of natural history of primary sclerosing cholangitis. Current Opinion in Gastroenterology 33:2, pages 71-77.
Crossref
Albert J. Czaja. 2017. Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis 41 57 .
Christopher L. Bowlus. 2017. Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis 1 11 .
Roger W. Chapman & Kate D. Williamson. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 531 547 .
José Franco. 2017. Liver Disorders. Liver Disorders 289 305 .
Hiep Nguyen Canh & Kenichi Harada. (2016) Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma. Medical Molecular Morphology 49:4, pages 189-202.
Crossref
Aida Kapic Lunder, Johannes Roksund Hov, Arne Borthne, Jostein Gleditsch, Glenn Johannesen, Knut Tveit, Ellen Viktil, Magne Henriksen, Øistein Hovde, Gert Huppertz-Hauss, Ole Høie, Marte Lie Høivik, Iril Monstad, Inger Camilla Solberg, Jørgen Jahnsen, Tom Hemming Karlsen, Bjørn Moum, Morten Vatn & Anne Negård. (2016) Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. Gastroenterology 151:4, pages 660-669.e4.
Crossref
Ramprasad Jegadeesan, Udayakumar Navaneethan, Shishira Bharadwaj, Jeffrey Hammel, Madhusudhan R. Sanaka & Bo Shen. (2016) Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 22:4, pages 948-954.
Crossref
Trine Folseraas & Kirsten Muri Boberg. (2016) Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease 20:1, pages 79-98.
Crossref
Jay H. Lefkowitch. 2016. Scheuer's Liver Biopsy Interpretation. Scheuer's Liver Biopsy Interpretation 53 81 .
José Franco. 2016. Pancreas and Biliary Disease. Pancreas and Biliary Disease 321 346 .
Jayant A. Talwalkar & Konstantinos N. Lazaridis. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1835 1847 .
H. Yanai, S. Matalon, A. Rosenblatt, H. Awadie, T. Berdichevski, Y. Snir, U. Kopylov, L. Katz, A. Stein, L. Mlynarsky, H. Tulchinsky, F. M. Konikoff, S. Ben Horin, M. Braun, Z. Ben-Ari, Y. Chowers, Y. Baruch, O. Shibolet & I. Dotan. (2014) Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease. Journal of Crohn's and Colitis 9:2, pages 177-184.
Crossref
Anil Seetharam & Jeffrey S. Crippin. 2015. Transplantation of the Liver. Transplantation of the Liver 167 173 .
Christos Tsaitas. (2014) Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World Journal of Hepatology 6:4, pages 178.
Crossref
Harald Hofer, Emina Halilbasic, Katharina Staufer & Michael Trauner. 2014. Liver Immunology. Liver Immunology 301 316 .
Rodrigo Liberal, Yoh Zen, Giorgina Mieli-Vergani & Diego Vergani. (2013) Liver transplantation and autoimmune liver diseases. Liver Transplantation 19:10, pages 1065-1077.
Crossref
David F. Schaeffer, Lay Lay Win, Sara Hafezi-Bakhtiari, Maria Cino, Gideon M. Hirschfield & Hala El-Zimaity. (2013) The Phenotypic Expression of Inflammatory Bowel Disease in Patients with Primary Sclerosing Cholangitis Differs in the Distribution of Colitis. Digestive Diseases and Sciences 58:9, pages 2608-2614.
Crossref
Lina Lindström, Rolf Hultcrantz, Kirsten Muri Boberg, Ingalill Friis–Liby & Annika Bergquist. (2013) Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 11:7, pages 841-846.
Crossref
Jimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, Eva Ellinghaus, Simon M Rushbrook, Nadezhda T Doncheva, Ole A Andreassen, Rinse K Weersma, Tobias J Weismüller, Bertus Eksteen, Pietro Invernizzi, Gideon M Hirschfield, Daniel Nils Gotthardt, Albert Pares, David Ellinghaus, Tejas Shah, Brian D Juran, Piotr Milkiewicz, Christian Rust, Christoph Schramm, Tobias Müller, Brijesh Srivastava, Georgios Dalekos, Markus M Nöthen, Stefan Herms, Juliane Winkelmann, Mitja Mitrovic, Felix Braun, Cyriel Y Ponsioen, Peter J P Croucher, Martina Sterneck, Andreas Teufel, Andrew L Mason, Janna Saarela, Virpi Leppa, Ruslan Dorfman, Domenico Alvaro, Annarosa Floreani, Suna Onengut-Gumuscu, Stephen S Rich, Wesley K Thompson, Andrew J Schork, Sigrid Næss, Ingo Thomsen, Gabriele Mayr, Inke R König, Kristian Hveem, Isabelle Cleynen, Javier Gutierrez-Achury, Isis Ricaño-Ponce, David van Heel, Einar Björnsson, Richard N Sandford, Peter R Durie, Espen Melum, Morten H Vatn, Mark S Silverberg, Richard H Duerr, Leonid Padyukov, Stephan Brand, Miquel Sans, Vito Annese, Jean-Paul Achkar, Kirsten Muri Boberg, Hanns-Ulrich Marschall, Olivier Chazouillères, Christopher L Bowlus, Cisca Wijmenga, Erik Schrumpf, Severine Vermeire, Mario Albrecht, John D Rioux, Graeme Alexander, Annika Bergquist, Judy Cho, Stefan Schreiber, Michael P Manns, Martti Färkkilä, Anders M Dale, Roger W Chapman, Konstantinos N Lazaridis, Andre Franke, Carl A Anderson & Tom H Karlsen. (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nature Genetics 45:6, pages 670-675.
Crossref
Donald E. Henson & Jorge Albores-Saavedra. (2012) An hypothesis on the presumed association between thyroid goiter and gastric cancer. Cancer Causes & Control 24:3, pages 609-610.
Crossref
Kristin Kaasen Jrgensen, Krzysztof Grzyb, Knut E.A. Lundin, Ole Petter F. Clausen, Geir Aamodt, Erik Schrumpf, Morten H. Vatn & Kirsten Muri Boberg. (2012) Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflammatory Bowel Diseases 18:3, pages 536-545.
Crossref
Kazuhiko Nakamura, Tetsuhide Ito, Kazuhiro Kotoh, Eikichi Ihara, Haruei Ogino, Tsutomu Iwasa, Yoshimasa Tanaka, Yoichiro Iboshi & Ryoichi Takayanagi. (2012) Hepatopancreatobiliary manifestations of inflammatory bowel disease. Clinical Journal of Gastroenterology 5:1, pages 1-8.
Crossref
Tom H. Karlsen, Kirsten Muri Boberg & Erik Schrumpf. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology 754 781 .
John Halliday & Roger W. Chapman. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis 579 600 .
Marcelo G. Roma, Flavia D. Toledo, Andrea C. Boaglio, Cecilia L. Basiglio, Fernando A. Crocenzi & Enrique J. Sánchez Pozzi. (2011) Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. Clinical Science 121:12, pages 523-544.
Crossref
Marion J. Pollheimer, Emina Halilbasic, Peter Fickert & Michael Trauner. (2011) Pathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 25:6, pages 727-739.
Crossref
David Goldberg, Benjamin French, Arwin Thomasson, K. Rajender Reddy & Scott D. Halpern. (2011) Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transplantation 17:11, pages 1355-1363.
Crossref
Laetitia E. Lamberts, Marcel Janse, Elizabeth B. Haagsma, Arie P. van den Berg & Rinse K. Weersma. (2011) Immune-mediated diseases in primary sclerosing cholangitis. Digestive and Liver Disease 43:10, pages 802-806.
Crossref
David Seth Goldberg, Benjamin French, Arwin Thomasson, K. Rajender Reddy & Scott D. Halpern. (2011) Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation 91:10, pages 1148-1152.
Crossref
Jochen Mattner. (2011) Genetic susceptibility to autoimmune liver disease. World Journal of Hepatology 3:1, pages 1.
Crossref
V.J. Desmet & Juan Rosai. 2011. Rosai and Ackerman's Surgical Pathology. Rosai and Ackerman's Surgical Pathology 857 980 .
Nandini Channabasappa, Sarah Johnson-Welch & Naveen Mittal. (2010) De novo cholangiocarcinoma after liver transplantation in a pediatric patient. Pediatric Transplantation 14:8, pages E110-E114.
Crossref
Tom H. Karlsen, Erik Schrumpf & Kirsten Muri Boberg. (2010) Primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 24:5, pages 655-666.
Crossref
Tom H. Karlsen, Erik Schrumpf & Kirsten M. Boberg. (2010) Update on primary sclerosing cholangitis. Digestive and Liver Disease 42:6, pages 390-400.
Crossref
Nobuaki Kawarabayashi, Shuhji Seki, Kazuo Hatsuse, Manabu Kinoshita, Toshimichi Takigawa, Hironori Tsujimoto, Toshinobu Kawabata, Hiroyuki Nakashima, Satoshi Shono & Hidetaka Mochizuki. (2010) IMMUNOSUPPRESSION IN THE LIVERS OF MICE WITH OBSTRUCTIVE JAUNDICE PARTICIPATES IN THEIR SUSCEPTIBILITY TO BACTERIAL INFECTION AND TUMOR METASTASIS. Shock 33:5, pages 500-506.
Crossref
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider & Gregory J. Gores. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51:2, pages 660-678.
Crossref
Adrian M. Di Bisceglie & Alex S. Befeler. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 1569 1592.e6 .
Andrew S. Ross & Kris V. Kowdley. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 1153 1170.e6 .
Jay H. Lefkowitch. 2010. Scheuer's Liver Biopsy Interpretation. Scheuer's Liver Biopsy Interpretation 47 74 .
Udayakumar Navaneethan, Feza H Remzi, Benjamin Nutter, Victor W Fazio & Bo Shen. (2009) Risk Factors for Abnormal Liver Function Tests in Patients With Ileal Pouch–Anal Anastomosis for Underlying Inflammatory Bowel Disease. The American Journal of Gastroenterology 104:10, pages 2467-2475.
Crossref
Anna Lepistö, Sari Kivistö, Leena Kivisaari, Johanna Arola & Heikki J. Järvinen. (2009) Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis. International Journal of Colorectal Disease 24:10, pages 1169-1174.
Crossref
Mee Joo, Paula Abreu-e-Lima, Francis Farraye, Timothy Smith, Prabhakar Swaroop, Laura Gardner, Gregory Y. Lauwers & Robert Daniel Odze. (2009) Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis. American Journal of Surgical Pathology 33:6, pages 854-862.
Crossref
Rolf Olsson, Hans Glaumann, Sven Almer, Ulrika Broomé, Barbro Lebrun, Annika Bergquist, Einar Björnsson, Hanne Prytz, Åke Danielsson & Stefan Lindgren. (2009) High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. European Journal of Internal Medicine 20:2, pages 190-196.
Crossref
Einar Björnsson. (2009) Small-duct primary sclerosing cholangitis. Current Gastroenterology Reports 11:1, pages 37-41.
Crossref
Karouk Said, Nick Edsborg, Nils Albiin & Annika Bergquist. (2009) Gallbladder emptying in patients with primary sclerosing cholangitis. World Journal of Gastroenterology 15:28, pages 3498.
Crossref
Fredric D. Gordon. (2008) Primary Sclerosing Cholangitis. Surgical Clinics of North America 88:6, pages 1385-1407.
Crossref
Tim R. Card, Masoud Solaymani-Dodaran & Joe West. (2008) Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study. Journal of Hepatology 48:6, pages 939-944.
Crossref
Anna Lepistö, Päivi Kärkkäinen & Heikki J. Järvinen. (2008) Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis. Inflammatory Bowel Diseases 14:6, pages 775-779.
Crossref
Susan N. Cullen, Christian Rust, Kenneth Fleming, Cathryn Edwards, Ulrich Beuers & Roger W. Chapman. (2008) High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective. Journal of Hepatology 48:5, pages 792-800.
Crossref
Einar Björnsson, Rolf Olsson, Annika Bergquist, Stefan Lindgren, Barbara Braden, Roger W. Chapman, Kirsten M. Boberg & Paul Angulo. (2008) The Natural History of Small-Duct Primary Sclerosing Cholangitis. Gastroenterology 134:4, pages 975-980.
Crossref
Mark McLoughlin & Robert Enns. (2008) Endoscopy in the management of primary sclerosing cholangitis. Current Gastroenterology Reports 10:2, pages 177-185.
Crossref
Gustav Paumgartner & Thomas Pusl. (2008) Medical Treatment of Cholestatic Liver Disease. Clinics in Liver Disease 12:1, pages 53-80.
Crossref
Harry Sokol, Jacques Cosnes, Olivier Chazouilleres, Laurent Beaugerie, Emmanuel Tiret, Raoul Poupon & Philippe Seksik. (2008) Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World Journal of Gastroenterology 14:22, pages 3497.
Crossref
Roger Chapman & Sue Cullen. (2008) Etiopathogenesis of primary sclerosing cholangitis. World Journal of Gastroenterology 14:21, pages 3350.
Crossref
Tobias J. Weismüller, Jochen Wedemeyer, Stefan Kubicka, Christian P. Strassburg & Michael P. Manns. (2008) The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy. Journal of Hepatology 48, pages S38-S57.
Crossref
Jawad Ahmad & Adam Slivka. 2008. ERCP. ERCP 379 386 .
. 2008. Surgery of the Anus, Rectum & Colon. Surgery of the Anus, Rectum & Colon 1487 1507 .
Michael P. Manns & Katja Deterding. 2008. Comparative Hepatitis. Comparative Hepatitis 1 20 .
Noam Harpaz. (2007) Neoplastic Precursor Lesions Related to the Development of Cancer in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 36:4, pages 901-926.
Crossref
Einar Björnsson & Paul Angulo. (2007) Cholangiocarcinoma in Young Individuals With and Without Primary Sclerosing Cholangitis. The American Journal of Gastroenterology 102:8, pages 1677-1682.
Crossref
Xiaofa Qin. (2007) Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: Where Is the Link?. The American Journal of Gastroenterology 102:6, pages 1332-1333.
Crossref
Nissa I. Erickson & William F. Balistreri. 2009. Liver Disease in Children. Liver Disease in Children 459 477 .
Gilaad G. Kaplan, Kevin B. Laupland, Decker Butzner, Stefan J. Urbanski & Samuel S. Lee. (2007) The Burden of Large and Small Duct Primary Sclerosing Cholangitis in Adults and Children: A Population-Based Analysis. The American Journal of Gastroenterology 102:5, pages 1042-1049.
Crossref
Sue Cullen & Roger Chapman. 2007. Liver Immunology. Liver Immunology 249 261 .
Markus H. Heim. 2006. Diseases of the Gallbladder and Bile Ducts. Diseases of the Gallbladder and Bile Ducts 58 67 .
Robert Enns. 2006. Diseases of the Gallbladder and Bile Ducts. Diseases of the Gallbladder and Bile Ducts 306 331 .
Priya Jamidar. (2006) Bile Duct Brushings for the Early Detection of Cholangiocarcinoma. Journal of Clinical Gastroenterology 40:4, pages 279-280.
Crossref
Roshan Shrestha & David M. S. Grunkemeier. (2006) Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation. Current Treatment Options in Gastroenterology 9:2, pages 133-144.
Crossref
Nida S. Awadallah, Yang K. Chen, Cyrus Piraka, Mainor R. Antillon & Raj J. Shah. (2006) Is There a Role for Cholangioscopy in Patients with Primary Sclerosing Cholangitis?. The American Journal of Gastroenterology 101:2, pages 284-291.
Crossref
Cynthia Levy, James Lymp, Paul Angulo, Gregory J. Gores, Nicholas Larusso & Keith D. Lindor. (2005) The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 50:9, pages 1734-1740.
Crossref
S. N. Cullen & R. W. Chapman. (2005) Review article: current management of primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics 21:8, pages 933-948.
Crossref
ALIREZA MOAYYERI, NASER EBRAHIMI DARYANI, HOSSEIN BAHRAMI, BABAK HAGHPANAH, ATOOSA NAYYER-HABIBI & MOHSEN SADATSAFAVI. (2005) Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. Journal of Gastroenterology and Hepatology 20:3, pages 366-370.
Crossref
Piero Portincasa. (2005) Primary sclerosing cholangitis: Updates in diagnosis and therapy. World Journal of Gastroenterology 11:1, pages 7.
Crossref
Jayant A. Talwalkar & Keith D. Lindor. (2005) Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 11:1, pages 62-72.
Crossref
K. M. Boberg & E. Schrumpf. 2005. Autoimmune Liver Disease. Autoimmune Liver Disease 233 246 .
R. Balfour Sartor & Steven N. Lichtman. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 305 335 .
Tim O. Hirche, Jan Russler, Barbara Braden, Gudrun Schuessler, Stefan Zeuzem, Till Wehrmann, Hans Seifert & Christoph F. Dietrich. (2004) Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. International Journal of Colorectal Disease 19:6, pages 586-594.
Crossref
J. Eaden. (2004) Colorectal carcinoma and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 20, pages 24-30.
Crossref
Kristian Bjøro & Erik Schrumpf. (2004) Liver transplantation for primary sclerosing cholangitis. Journal of Hepatology 40:4, pages 570-577.
Crossref
Kelly Burak, Paul Angulo, Tousif M Pasha, Kathleen Egan, Jan Petz & Keith D Lindor. (2004) Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis. American Journal of Gastroenterology 99:3, pages 523-526.
Crossref
Xuesong Yang, Susan N Cullen, Jin H Li, Roger W Chapman & Derek P Jewell. (2004) Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. Journal of Hepatology 40:3, pages 375-379.
Crossref
Michael Trauner & Peter L. M. JansenEinar Björnsson & Roger W. Chapman. 2004. Molecular Pathogenesis of Cholestasis. Molecular Pathogenesis of Cholestasis 247 255 .
Kiran Bambha, W.Ray Kim, Jayant Talwalkar, Heidi Torgerson, Joanne T Benson, Terry M Therneau, Edward V LoftusJrJr, Barbara P Yawn, E.Rolland Dickson & L.Joseph MeltonIIIIII. (2003) Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community. Gastroenterology 125:5, pages 1364-1369.
Crossref
B Brandsæter. (2003) Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list. Liver Transplantation 9:9, pages 961-969.
Crossref
T.M Neri, G.M Cavestro, P Seghini, P.F Zanelli, A Zanetti, M Savi, M Podda, M Zuin, M Colombo, A Floreani, F Rosina, G Bianchi Porro, M Strazzabosco & L Okolicsanyi. (2003) Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Digestive and Liver Disease 35:8, pages 571-576.
Crossref
Michael A. Heneghan, J. Elizabeth Tuttle-Newhall, Paul V. Suhocki, Andrew J. Muir, Michael Morse, Jeffrey D. Bornstein, Pamela B. Sylvestre, Bradley Collins, Paul C. Kuo & Don C. Rockey. (2003) De-Novo Cholangiocarcinoma in the Setting of Recurrent Primary Sclerosing Cholangitis Following Liver Transplant. American Journal of Transplantation 3:5, pages 634-638.
Crossref
R. Balfour Sartor & Steven N. Lichtman. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 305 335 .
Daniel Resnick, Glenn A. Krinsky, Michael T. Lavelle, Vivian S. Lee, Mary T. Keogan & Martina M. Morrin. (2002) Do Patients with Primary Sclerosing Cholangitis Have a Greater Frequency of Pancreatic Abnormalities at MRI than Patients with Other Liver Diseases?. Journal of Computer Assisted Tomography 26:6, pages 994-999.
Crossref
Tiing Leong Ang, Kwong Ming Fock, Tay Meng Ng, Eng Kiong Teo, Tju Siang Chua & Jessica Yi-Lyn Tan. (2002) Clinical profile of primary sclerosing cholangitis in Singapore. Journal of Gastroenterology and Hepatology 17:8, pages 908-913.
Crossref
Roy M. Soetikno, Otto S. Lin, Paul A. Heidenreich, Harvey S. Young & Michael O. Blackstone. (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis. Gastrointestinal Endoscopy 56:1, pages 48-54.
Crossref
Paul Angulo, Yaakov Maor-Kendler & Keith D. Lindor. (2002) Small-duct primary sclerosing cholangitis: A long-term follow-up study. Hepatology 35:6, pages 1494-1500.
Crossref
Daniel C. Buckles, Keith D. Lindor, Nicholas F. LaRusso, Lydia M. Petrovic & Gregory J. Gores. (2002) In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. The American Journal of Gastroenterology 97:5, pages 1138-1142.
Crossref
Jawad Ahmad & Adam Slivka. (2002) Hepatobiliary disease in inflammatory bowel disease. Gastroenterology Clinics of North America 31:1, pages 329-345.
Crossref
Rupam Sharan & Robert E Schoen. (2002) Cancer in inflammatory bowel disease. Gastroenterology Clinics of North America 31:1, pages 237-254.
Crossref
Erwin Kuntz & Hans-Dieter KuntzErwin Kuntz & Hans-Dieter Kuntz. 2002. Hepatology. Hepatology 575 612 .
. 2001. Diseases of the Liver and Biliary System. Diseases of the Liver and Biliary System 255 265 .
Erkan Parlak, Yasemin Kosar, Aysel Ulker, Ulku Dagli, Canan Alkim & Burhan Sahin. (2001) Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease in Turkey. Journal of Clinical Gastroenterology 33:4, pages 299-301.
Crossref
W. A. FaubionJr.Jr., E. V. Loftus, W. J. Sandborn, D. K. Freese & J. Perrault. (2001) Pediatric “PSC-IBD”: A Descriptive Report of Associated Inflammatory Bowel Disease Among Pediatric Patients With PSC. Journal of Pediatric Gastroenterology and Nutrition 33:3, pages 296-300.
Crossref
Russell H. Wiesner. (2001) Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Practice & Research Clinical Gastroenterology 15:4, pages 667-680.
Crossref
Sue Cullen & Roger Chapman. (2001) Aetiopathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 577-589.
Crossref
Jayant A. Talwalkar & Keith D. Lindor. (2001) Natural history and prognostic models in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 563-575.
Crossref
Erik Schrumpf & Kirsten Muri Boberg. (2001) Epidemiology of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 553-562.
Crossref
M. Barthet. (2001) Maladies inflammatoires chroniques de l'intestin. Acta Endoscopica 31:S4, pages 576-582.
Crossref
Marjut Leidenius, Krister Höckerstedt, Ulrika Broomé, Bo-Göran Ericzon, Styrbjörn Friman, Michael Olausson & Erik Schrumpf. (2001) Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. Journal of Hepatology 34:6, pages 792-798.
Crossref
Suzanne Norris, Elli Kondeatis, Robert Collins, Henry Stephens, Phillip Harrison, Robert Vaughan, Mike Clare, Jack Satsangi, Roger Chapman & Peter Donaldson. (2001) Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: The role of MICA polymorphism. Gastroenterology 120:6, pages 1475-1482.
Crossref
Roshan Shrestha & Hugh Lasch. (2001) Endoscopic Therapy for Biliary Tract Disease Before Orthotopic Liver Transplantation. Gastrointestinal Endoscopy Clinics of North America 11:1, pages 45-64.
Crossref
Gregory J. Gores. (2000) Early detection and treatment of cholangiocarcinoma. Liver Transplantation 6:6B, pages s30-s34.
Crossref
Jayne A Eaden & John F Mayberry. (2000) Colorectal Cancer Complicating Ulcerative Colitis: A Review. American Journal of Gastroenterology 95:10, pages 2710-2719.
Crossref
Mark A. Gilger, Mary E. Gann, Antone R. Opekun & Wallace A. GleasonJr.Jr.. (2000) Efficacy of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis in Children. Journal of Pediatric Gastroenterology and Nutrition 31:2, pages 136-141.
Crossref
Kenneth M. Vitellas, Mary T. Keogan, Kelly S. Freed, Robert A. Enns, Charles E. Spritzer, John M. Baillie & Rendon C. Nelson. (2000) Radiologic Manifestations of Sclerosing Cholangitis with Emphasis on MR Cholangiopancreatography. RadioGraphics 20:4, pages 959-975.
Crossref
Sheila Sherlock. (2000) PRIMARY BILIARY CIRRHOSIS, PRIMARY SCLEROSING CHOLANGITIS, AND AUTOIMMUNE CHOLANGITIS. Clinics in Liver Disease 4:1, pages 97-113.
Crossref
Mitsuru Seo, Mitsuo Okada, Motonobu Kanda, Hiroshi Murayama, Shunji Osamura, Kouji Ohdera, Yoshiki Egashira & Toshimi Umeno. (2001) Carcinoma of the gall‐bladder associated with primary sclerosing cholangitis and ulcerative colitis. Digestive Endoscopy 12:1, pages 46-51.
Crossref
Naga Chalasani, Arthur Baluyut, Ayaaz Ismail, Atif Zaman, Gagan Sood, Reem Ghalib, T. M. McCashland, K. Rajender Reddy, Xaralambos Zervos, Mann A. Anbari & Helena Hoen. (2000) Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 31:1, pages 7-11.
Crossref
E. Björnsson, A. Kilander & R. Olsson. (2008) CA 19–9 and CE A are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 19:6, pages 501-508.
Crossref
Paul Angulo, Dirk R Larson, Terry M Therneau, Nicholas F LaRusso, Kenneth P Batts & Keith D Lindor. (1999) Time Course of Histological Progression in Primary Sclerosing Cholangitis. American Journal of Gastroenterology 94:11, pages 3310-3313.
Crossref
Paul Angulo & Keith D. Lindor. (1999) PRIMARY BILIARY CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS. Clinics in Liver Disease 3:3, pages 529-570.
Crossref
Paul Angulo & Keith D. Lindor. (1999) Primary sclerosing cholangitis. Hepatology 30:1, pages 325-332.
Crossref
Per Karlén, Robert Löfberg, Olle Broström, Carl-Eric Leijonmarck, Göran Hellers & Per-Gunnar Persson. (1999) Increased Risk of Cancer in Ulcerative Colitis: A Population-Based Cohort Study. American Journal of Gastroenterology 94:4, pages 1047-1052.
Crossref
José Franco & Kia Saeian. (1999) Biliary tract inflammatory disorders: Primary sclerosing cholangitis and primary biliary cirrhosis. Current Gastroenterology Reports 1:2, pages 95-101.
Crossref
R.W. Chapman. (1999) Risk factors for biliary tract carcinogenesis. Annals of Oncology 10, pages S308-S312.
Crossref
Marco Bacosi, Marco Delle Monache, Francesca Russo & Giovanni L. Ricci. 1999. Advances in Abdominal Surgery. Advances in Abdominal Surgery 197 221 .
Susanne Keiding, S�ren B. Hansen, Henrik H Rasmussen, Antony Gee, Aksel Kruse, Klaus Roelsgaard, Ulrik Tage-Jensen & Jens Frederik Dahlerup. (1998) Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 28:3, pages 700-706.
Crossref
Blake A. Jones & Gregory J. Gores. (1998) HEPATOBILIARY MALIGNANCY. Clinics in Liver Disease 2:2, pages 437-449.
Crossref
Annika Bergquist & Ulrika Broomé. (1998) CLINICAL FEATURES IN PRIMARY SCLEROSING CHOLANGITIS. Clinics in Liver Disease 2:2, pages 283-301.
Crossref
Cyriel IJ Ponsioen & Guido N J Tytgat. (1998) Primary Sclerosing Cholangitis: A Clinical Review. American Journal of Gastroenterology 93:4, pages 515-523.
Crossref
Santiago Otero Lopez–Cubero, Keith M. Sullivan & George B. McDonald. (1998) Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 114:3, pages 433-440.
Crossref
Edward V. Loftus, Humberto I. Aguilar, William J. Sandborn, William J. Tremaine, Ruud A. Krom, Alan R. Zinsmeister, Ivo W. Graziadei & Russell H. Wiesner. (1998) Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27:3, pages 685-690.
Crossref
Stephen E. Silvis, Douglas B. Nelson & Peter B. Meier. (1998) Ten-year response to stenting in a patient with primary sclerosing cholangitis. Gastrointestinal Endoscopy 47:1, pages 83-87.
Crossref
John A. Goss, Christopher R. Shackleton, Douglas G. Farmer, Walid S. Arnaout, Philip Seu, Jay S. Markowitz, Paul Martin, Risë J. Stribling, Leonard I. Goldstein & Ronald W. Busuttil. (1997) Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis. Annals of Surgery 225:5, pages 472-483.
Crossref
Karin Lundqvist & Ulrika Broomé. (1997) Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis. Diseases of the Colon & Rectum 40:4, pages 451-456.
Crossref
Keith B. Noack & Tony Speer. (1997) 6 Investigation of the patient with abnormal liver function tests. Baillière's Clinical Gastroenterology 11:1, pages 83-95.
Crossref
Steven H. Itzkowitz. (1997) INFLAMMATORY BOWEL DISEASE AND CANCER. Gastroenterology Clinics of North America 26:1, pages 129-139.
Crossref
Mitsuru Seo, Mitsuo Okada, Shunji Osamura, Shinobu Hara, Toshimi Umeno, Kanekiyo Maeshiro, Yutaka Yamada & Kouichi Yuh. (1997) Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis. Journal of Gastroenterology 32:1, pages 83-88.
Crossref
Steven A. Ahrendt & Henry A. Pitt. (1996) Sclerosing cholangitis. Journal of Hepato-Biliary-Pancreatic Surgery 3:4, pages 431-441.
Crossref
Carlos A. CamargoJr.Jr., Mary K. Washington, J. Gregory Fitz & Pierre-Alain Clavien. (1996) Adult presentation of diffuse bile duct stenosis: Therapy with liver transplantation. Liver Transplantation and Surgery 2:3, pages 235-237.
Crossref
U Broome, R Olsson, L Loof, G Bodemar, R Hultcrantz, A Danielsson, H Prytz, H Sandberg-Gertzen, S Wallerstedt & G Lindberg. (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.. Gut 38:4, pages 610-615.
Crossref
Osvaldo Fracassetti, Giacomo Delvecchio, Roberto Tambini, Natale Lorenzi & Giovanna Gavazzeni. (1996) Primary Sclerosing Cholangitis with Celiac Sprue: Two Cases. Journal of Clinical Gastroenterology 22:1, pages 71-72.
Crossref
John Meenan, Eric A. Rauws & Kees Huibregtse. (1996) Benign Biliary Strictures and Sclerosing Cholangitis. Gastrointestinal Endoscopy Clinics of North America 6:1, pages 127-138.
Crossref
R. PichlmayrB. Nashan, G. Tusch, H. J. Schlitt & R. Pichlmayr. 1996. Wahrung des Bestandes, Wandel und Fortschritt der Chirurgie. Wahrung des Bestandes, Wandel und Fortschritt der Chirurgie 410 412 .
Ulrika Broomé, Robert Löfberg, Karin Lundqvist & Béla Veress. (1995) Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Diseases of the Colon & Rectum 38:12, pages 1301-1305.
Crossref
Ulrika Broomé, Robert Löfberg, Béla Veress & Ljusk Siw Eriksson. (1995) Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential. Hepatology 22:5, pages 1404-1408.
Crossref
Vijayan Balan & Nicholas F. LaRusso. (1995) HEPATOBILIARY DISEASE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 24:3, pages 647-669.
Crossref
Young-Mee Lee & Marshall M. Kaplan. (1995) Primary Sclerosing Cholangitis. New England Journal of Medicine 332:14, pages 924-933.
Crossref
MARJUT H. K. LEIDENIUS, SAIJA A. KOSKIMIES, ILMO H. KELLOKUMPU & KRISTER A. V. HÖCKERSTEDT. (2009) HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103:7-8, pages 519-524.
Crossref
Olivier Farges, Benoit Malassagne, Mylène Sebagh & Henri Bismuth. (1995) Primary sclerosing cholangitis: Liver transplantation or biliary surgery. Surgery 117:2, pages 146-155.
Crossref
Lene Mellemkjaer, Jsorgen H. Olsen, Morten Frisch, Christoffer Johansen, Gloria Gridley & Joseph K. McLaughlin. (2006) Cancer in patients with ulcerative colitis. International Journal of Cancer 60:3, pages 330-333.
Crossref
William J. Sandborn. (1995) A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 1:1, pages 48-63.
Crossref
Henry A. Pitt, Charles J. Yeo, William C. Dooley & John L. Cameron. (1995) Malignancies of the biliary tree. Current Problems in Surgery 32:1, pages 1-90.
Crossref
Ahmet K. Gurbuz, Francis M. Giardiello & Theodore M. Bayless. (1995) Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Diseases of the Colon & Rectum 38:1, pages 37-41.
Crossref
Alex Harmatz. (1994) Hepatobiliary manifestations of inflammatory bowel disease. Medical Clinics of North America 78:6, pages 1387-1398.
Crossref
RUSSELL H. WIESNER. (1994) Current Concepts in Primary Sclerosing Cholangitis. Mayo Clinic Proceedings 69:10, pages 969-982.
Crossref
Shinji Yamada, Motoyasu Ishii, Liu Shi Liang, Takeshi Yamamoto & Takayoshi Toyota. (1994) Small duct cholangitis induced byn-formyll-methioninel-leucinel-tyrosine in rats. Journal of Gastroenterology 29:5, pages 631-636.
Crossref
Eduardo B.G. Martins, Kenneth A. Fleming, Maria C. Garrido, Keith R. Hine & Roger W.G. Chapman. (1994) Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 107:2, pages 537-542.
Crossref
Yoshiyuki Ueno & Nicholas F. LaRusso. (1994) Primary sclerosing cholangitis. Journal of Gastroenterology 29:4, pages 531-543.
Crossref
Erik Schrumpf, Michel Abdelnoor, Olav Fausa, Kjell Elgjo, Eystein Jenssen & Finn Kolmannskog. (1994) Risk factors in primary sclerosing cholangitis. Journal of Hepatology 21:6, pages 1061-1066.
Crossref
Ulrika Broomé & Ljusk Siw Eriksson. (1994) Assessment for liver transplantation in patients with primary sclerosing cholangitis. Journal of Hepatology 20:5, pages 654-659.
Crossref
Aditya Mandal, Arunansu Dasgupta, Lenox Jeffers, Linda Squillante, Shakir Hyder, Rajender Reddy, Eugene Schiff & Kiron M. Das. (1994) Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 106:1, pages 185-192.
Crossref
S. STRASSER, A. G. R. SHEIL, N. D. GALLAGHER, R. WAUGH & G. W. McCAUGHAN. (2008) Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: A comparison of complications and outcome. Journal of Gastroenterology and Hepatology 8:3, pages 238-243.
Crossref
E. HASHIMOTO, M. IDETA, M. TANIAI, U. WATANABE, H. OKUDA, K. NAGASAKO, T. HISAMITSU & H. OBATA. (2008) Prevalence of primary sclerosing cholangitis and other liver diseases in Japanese patients with chronic ulcerative colitis. Journal of Gastroenterology and Hepatology 8:2, pages 146-149.
Crossref
W J Sandborn, R H Wiesner, W J Tremaine & N F Larusso. (1993) Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.. Gut 34:2, pages 242-246.
Crossref
Ulrika Broomé, Greger Lindberg & Robert Löfberg. (1992) Reply. Gastroenterology 103:5, pages 1708-1709.
Crossref
WILLIAM J. SANDBORN & WILLIAM J. TREMAINE. (1992) Cyclosporine Treatment of Inflammatory Bowel Disease. Mayo Clinic Proceedings 67:10, pages 981-990.
Crossref
Ulrich Beuers, Ulrich Spengler, Wolfgang Kruis, ülker Aydemir, Baldur Wiebecke, Walter Heldwein, Marlene Weinzierl, Gerd R. Pape, Tilman Sauerbruch & Gustav Paumgartner. (1992) Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial. Hepatology 16:3, pages 707-714.
Crossref
Stephen Hanauer. (1992) Primary sclerosing cholangitis and ulcerative colitis: Potential cofactors in the dysplasia sequence. Gastroenterology 102:6, pages 2161-2162.
Crossref
R W Chapman. (1991) Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?. Gut 32:12, pages 1433-1435.
Crossref
M Miros, P Kerlin, N Walker, J Harper, S Lynch & R Strong. (1991) Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation.. Gut 32:11, pages 1369-1373.
Crossref

Displaying 200 of 215 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.